Vaxxa AB (FRA:7WA0) 3-Year ROIIC % : -523.29% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7WA0 Vaxxa AB FRA:7WA0
25 GF Score
Price €0.03
GF Value €0.06
View Full Analysis

What is Vaxxa AB 3-Year ROIIC %?

Vaxxa AB FRA:7WA0 -2.92% 25 3-Year ROIIC % is -523.29 as of Dec. 2025. GuruFocus rates FRA:7WA0 with a GF Score™ of 25/100 and a GF Value™ of €0.06. Among 2,624 Software companies, Vaxxa AB ranks worse than 97.94% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Vaxxa AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -523.29%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Vaxxa AB's 3-Year ROIIC % or its related term are showing as below:

FRA:7WA0's 3-Year ROIIC % is ranked worse than
97.94% of 2624 companies
in the Software industry
Industry Median: 5.335 vs FRA:7WA0: -523.29

Vaxxa AB  (FRA:7WA0) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Vaxxa AB 3-Year ROIIC % Related Terms


Vaxxa AB 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Vaxxa AB's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxxa AB 3-Year ROIIC % Chart

Vaxxa AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -75.48 17.30 10.66 64.74 -523.29

Vaxxa AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -523.29 0.00 0.00

FRA:7WA0 vs UBER, SHOP, CRM: 3-Year ROIIC % Comparison

For the Software - Application subindustry, Vaxxa AB's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxxa AB 3-Year ROIIC % vs Software Industry

For the Software industry and Technology sector, Vaxxa AB's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Vaxxa AB's 3-Year ROIIC % falls into.


FRA:7WA0
25GF Score
Vaxxa AB FRA:7WA0
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxxa AB 3-Year ROIIC % Calculation

Vaxxa AB's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -0.862 (Dec. 2025) - -0.214 (Dec. 2022) )/( 1.735 (Dec. 2025) - 1.595 (Dec. 2022) )
=-0.648/0.14
=-462.86%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of -523.29 mean?
Vaxxa AB (FRA:7WA0) has a 3-Year ROIIC % of -523.29 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vaxxa AB and its competitors. According to the industry distribution chart, Vaxxa AB ranks #2570 out of 2624 companies in the Software industry, placing it in the top 97.9%.
Is Vaxxa AB's 3-Year ROIIC % too high?
Vaxxa AB's current 3-Year ROIIC % is -523.29. Based on the distribution chart, Vaxxa AB ranks #2570 out of 2624 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Vaxxa AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's 3-Year ROIIC % compare to UBER and SHOP?
According to the Software industry distribution chart, Vaxxa AB ranks #2570 out of 2624 companies for 3-Year ROIIC %. This places Vaxxa AB in the lower half of its industry. The industry median 3-Year ROIIC % is 5.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Software company?
The median 3-Year ROIIC % among Software companies is 5.34, based on 2,624 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vaxxa AB and its competitors. For the Software industry, the median 3-Year ROIIC % is 5.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaxxa AB's current 3-Year ROIIC % is -523.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Vaxxa AB (FRA:7WA0) has a current 3-Year ROIIC % of -523.29. The stock's GF Value™ is €0.06, compared to a current price of €0.03 — trading 44.7% below its estimated fair value. The current 3-Year ROIIC % is -523.29. Vaxxa AB's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Vaxxa AB (FRA:7WA0), the current 3-Year ROIIC % is -523.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxxa AB (FRA:7WA0) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued. The current stock price of €0.03 is trading 44.7% below its estimated GF Value™ of €0.06.

Key valuation signals for FRA:7WA0:

  • 3-Year ROIIC %: -523.29
  • GF Value™: €0.06 vs. price of €0.03 (44.7% below fair value)
  • GF Score™: 25/100

No single metric tells the full story. See the FRA:7WA0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vaxxa AB Business Description

Other Exchanges VAXXA:Sweden
Address Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
25GF Score

Get the complete analysis for FRA:7WA0

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.06
GF Value